Fineline Cube

Follow:
14420 Articles
China's NHSA and NHC Issue Guidelines to Enhance Volume-based Procurement Mechanism
Policy / Regulatory

China’s NHSA and NHC Issue Guidelines to Enhance Volume-based Procurement Mechanism

CSPC Pharmaceutical Group's SYHX2011 for Metastatic Breast Cancer Accepted for NMPA Review
CompanyDrug

CSPC Pharmaceutical Group’s SYHX2011 for Metastatic Breast Cancer Accepted for NMPA Review

GSK's Nucala Receives FDA Review for COPD Indication Based on MATINEE Study Data
CompanyDrug

GSK’s Nucala Receives FDA Review for COPD Indication Based on MATINEE Study Data

Hantech Medical Device Co., Ltd Acquires BD's Villamarzana Factory to Expand Manufacturing
CompanyDeals

Hantech Medical Device Co., Ltd Acquires BD’s Villamarzana Factory to Expand Manufacturing

Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies
CompanyDeals

Precision Biotech and T&L Biotechnology Form Partnership to Advance Cell and Gene Therapies

MicroPort Scientific Corp. Launches FireFalcon Balloon for Coronary Interventions with NMPA Approval
CompanyMedical Device

MicroPort Scientific Corp. Launches FireFalcon Balloon for Coronary Interventions with NMPA Approval

HuidaGene Therapeutics Initiates HERO Trial for RNA-Editing Therapy HG204 in MECP2 Duplication Syndrome
CompanyDrug

HuidaGene Therapeutics Initiates HERO Trial for RNA-Editing Therapy HG204 in MECP2 Duplication Syndrome

Simcere Pharmaceutical's SIM0508 Reaches First Patient Dosing in Global Clinical Study
CompanyDrug

Simcere Pharmaceutical’s SIM0508 Reaches First Patient Dosing in Global Clinical Study

Livzon Pharmaceutical Group Inks Influenza Vaccine Patent Deal with South China Vaccine Corporation
CompanyDeals

Livzon Pharmaceutical Group Inks Influenza Vaccine Patent Deal with South China Vaccine Corporation

WuXi AppTec's Subsidiary Invests EUR 20 Million in Jeito II S.L.P. for Growth Expansion
CompanyDeals

WuXi AppTec’s Subsidiary Invests EUR 20 Million in Jeito II S.L.P. for Growth Expansion

TJ Biopharma and Jumpcan Pharmaceutical Announce NMPA Review of Eftansomatropin Alfa BLA
CompanyDrug

TJ Biopharma and Jumpcan Pharmaceutical Announce NMPA Review of Eftansomatropin Alfa BLA

AstraZeneca's Imfinzi Receives FDA Priority Review for Muscle-Invasive Bladder Cancer
CompanyDrug

AstraZeneca’s Imfinzi Receives FDA Priority Review for Muscle-Invasive Bladder Cancer